CISPLATIN AND VINDESINE COMBINATION CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL COMPARING 2 DOSAGES OF CISPLATIN

被引：0
|
作者：
SHINKAI, T
SAIJO, N
EGUCHI, K
SASAKI, Y
TOMINAGA, K
SAKURAI, M
SUGA, J
MIYAOKA, H
SANO, T
KEICHO, N
TAKAHASHI, H
ISHIHARA, J
TAMURA, T
HOSHI, A
JETT, JR
机构：
[1] NATL CANC CTR,RES INST,DIV PHARMACOL,CHUO KU,TOKYO 104,JAPAN
[2] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
来源：
JAPANESE JOURNAL OF CANCER RESEARCH | 1986年 / 77卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：782 / 789
页数：8
相关论文
共 50 条
  • [41] MITOMYCIN (M), VINBLASTINE (V), AND CISPLATIN (P) COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    MASON, BA
    CATALANO, RB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 447 - 447
  • [42] PHASE II STUDY OF IFOSFAMIDE, CISPLATIN, AND VINDESINE COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    OHNOSHI, T
    HIRAKI, S
    UEDA, N
    FUJII, M
    MACHIDA, K
    UEOKA, H
    KAWAHARA, S
    KOZUKA, A
    KIURA, K
    MORITAKA, T
    KODANI, T
    KAMEI, H
    KIMURA, I
    ACTA MEDICA OKAYAMA, 1991, 45 (05) : 357 - 361
  • [43] MITOMYCIN-C, VINBLASTINE AND CISPLATIN COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER
    NOMURA, F
    SHIMOKATA, K
    SAITO, H
    SAKAI, S
    WATANABE, A
    SAKA, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (04) : 324 - 326
  • [44] Sequential combination chemotherapy for advanced non-small cell lung cancer: Paclitaxel and cisplatin followed by vinorelbine and cisplatin
    Kim, H
    Kwon, J
    Jung, J
    Kim, J
    Song, H
    Lee, K
    Zang, D
    Ahn, J
    Lee, J
    Park, Y
    LUNG CANCER, 2005, 49 : S253 - S253
  • [45] COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER
    MUNDIA, A
    CORTES, EP
    CHITKARA, R
    AKBIYIK, N
    SERIFF, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 107 - 107
  • [46] COMPARATIVE RANDOMIZED STUDY OF CHEST RADIOTHERAPY PRECEDED OR NOT BY CHEMOTHERAPY WITH CISPLATIN, ETOPOSIDE AND VINDESINE FOR THE TREATMENT OF NON SMALL CELL LUNG-CANCER (NSCLC)
    VANHOUTTE, P
    KLASTERSKY, J
    NGUYEN, H
    MICHEL, J
    VANDERMOTEN, G
    ROCMANS, P
    DUMONT, JP
    DEVRIENDT, J
    SCULIER, JP
    LONGEVAL, E
    FLEMALE, A
    MOMMEN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 198 - 198
  • [47] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer
    Hasturk, S
    Hatabay, N
    Ece, F
    Karatas, M
    Hanta, I
    LUNG CANCER, 2005, 49 : S247 - S247
  • [48] Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancer
    Pujol, JL
    Quantin, X
    Choma, D
    Jacot, W
    Khial, F
    LUNG CANCER, 2002, 38 : S57 - S60
  • [49] Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer
    Sacristán, JA
    Kennedy-Martin, T
    Rosell, R
    Cardenal, F
    Antón, A
    Lomas, M
    Alberola, V
    Massuti, B
    Carrato, A
    Minshall, M
    LUNG CANCER, 2000, 28 (02) : 97 - 107
  • [50] A RANDOMIZED TRIAL COMPARING VINDESINE VDS WITH VINDESINE PLUS CIS-PLATINUM (DDP) IN INOPERABLE NON-SMALL CELL LUNG-CANCER (NSCLC)
    ELLIOTT, JA
    AHMEDZAI, S
    STEVENSON, RD
    DORWARD, AJ
    CALMAN, KC
    BRITISH JOURNAL OF CANCER, 1982, 46 (03) : 485 - 486
12345